BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SenzaGen - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://senzagen.com
X-WR-CALDESC:Events for SenzaGen
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260629
DTEND;VALUE=DATE:20260703
DTSTAMP:20260630T092524Z
CREATED:20260123T090400Z
LAST-MODIFIED:20260630T092524Z
UID:36525-1782691200-1783036799@senzagen.com
SUMMARY:ESTIV 2026
DESCRIPTION:Maastricht\, the Netherlands\n“Ensuring Safety\, Advancing Science: Bridging to the Future with NAMs” \nPosters\nTuesday\, 30 June \nP23: #272 – “Adapting RNA-seq as an alternative acquisition platform for gene expression quantification in the GARDskin assay” \np71: #269 – “In vitro sensitization assessment of medical device extracts: Prevalidation results of GARDskin Medical Device for potential inclusion in ISO 10993-10”
URL:https://senzagen.com/event/estiv-2026/
LOCATION:Maastricht
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2026/01/2026-ESTIV-eventpage-banner-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260913
DTEND;VALUE=DATE:20260917
DTSTAMP:20260827T083829Z
CREATED:20260123T082112Z
LAST-MODIFIED:20260827T083829Z
UID:36512-1789257600-1789603199@senzagen.com
SUMMARY:Eurotox 2026
DESCRIPTION:Come meet us at Booth #58 and join our scientific session and poster presentations\, showcasing the latest GARD® data and case studies generated in collaboration with industry leaders. \n \nSenzaGen-hosted session\nHall M | Tuesday\, 15 September | 12:15 – 13:15\nAdvancing NAMs for skin and respiratory sensitization testing: Industry case studies on Essential Oils\, Natural Extracts\, and Difficult-to-test samples\n \nFeaturing guest speakers from ExxonMobil\, dōTERRA\, and the Research Institute for Fragrance Materials (RIFM)\, this session will highlight how GARD® data support Quantitative Risk Assessment and regulatory testing under OECD DA 497. \n  \nAgenda\n1. Introduction to the GARD® technology for skin and respiratory sensitization testing \nAndy Forreryd\, PhD |  Scientific Liaison\, SenzaGen \n2. Application of the “2 out of 3” Defined Approach (OECD 497) to assess skin sensitization potential of Difficult-to-test substances \nMegan Solan\, PhD | Toxicologist\, ExxonMobil Biomedical Sciences \n3. A comparative analysis of test methods for predicting dermal sensitization potency in Essential Oils \nJoe Dawson | Product Safety Manager\, dōTERRA \n4. Case study of GARD®skin Dose-Response on Natural Extracts and Quantitative Risk Assessment \nIsabelle Lee\, PhD | Manager of Human Health Science and Strategy\, RIFM \nPoster presentations\nSpotlight on Natural Complex Substances and In silico methods for Enviromental Risk Assessment\n P21-22 #1612 | Joint poster presented by ICCS \nRoom 0.11-0.12 | Tue\, 15 September | 09:30 \nAdaptation of the Next‑Generation Risk Assessment Framework for Skin Sensitization for the use of Natural Complex Substances  \n P18-74 #1159 | Poster presented by ToxHub \nRoom 0.11-0.12 | Mon\, 14 September | 09:30 \nReliability of QSAR-Based LogKow predictions in pharmaceutical Environmental Risk Assessment \nMore at our booth\nRegulatory expertise now complemented by in silico toxicology services\nMeet ToxHub\, our consultancy unit specializing in toxicological risk assessment and regulatory strategy consulting\, with expertise across medical devices\, pharmaceuticals\, cosmetics and chemicals. \nToxHub has recently lauched a new in silico toxicology service area\, providing QSAR-based hazard profiling to support both human health and environmental endpoints. \nDiscover how ToxHub can support your needs
URL:https://senzagen.com/event/eurotox-2026/
LOCATION:Vienna\, Austria
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2026/01/Lime-Evite_2026-Eurotox-Lime-banner_v1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261013
DTEND;VALUE=DATE:20261015
DTSTAMP:20261009T083301Z
CREATED:20260916T104449Z
LAST-MODIFIED:20261009T083301Z
UID:37458-1791849600-1792022399@senzagen.com
SUMMARY:Biocompatibility Insights 2026
DESCRIPTION:Biocompatibility Insights 2026\n Copenhagen\, Denmark\nDr. Andy Forreryd has been invited to speak at Biocompatibility Insights 2026. His presentation will focus on the growing adoption of non-animal methods in medical device testing\, highlighting regulatory updates and industry applications. \n  \n \n 
URL:https://senzagen.com/event/biocompatibility-insights-2026/
LOCATION:Copenhagen\, Denmark
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2026/09/2026-Biocompatibility-insights-event-page-banner.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261115
DTEND;VALUE=DATE:20261119
DTSTAMP:20261110T080858Z
CREATED:20260911T135953Z
LAST-MODIFIED:20261110T080858Z
UID:37420-1794700800-1795046399@senzagen.com
SUMMARY:ACT 2026
DESCRIPTION:American College of Toxicology (ACT) 47th Annual Meeting\n San Antonio\, USA\nAdvancing NAMs for Skin and Respiratory Sensitization Testing\nGARD®air for occupational health-related chemicals | Microorganisms | Proteins \nJoin us to discuss the latest developments in GARD® technology and explore how genomics- and machine learning-based approaches are supporting human-relevant sensitization assessment for product development and regulatory decision-making. \n \nPoster: Essential oils and quantitative potency assessment\nMonday\, 16 November\, 5:00 pm -6:30 pm \nDr Tim Lindberg | P204 | #2444913 – “Assessing skin sensitization potency and thresholds in Essential Oils: A comparative study using human data\, LLNA\, and GARD®skin Dose-Response” \n  \nNew: Immunotoxicology and biologics\nMonoclonal Antibodies | T-Cell Engagers | Bispecific Therapies \nWe are pleased to welcome Alcyomics to the SenzaGen Group\, expanding our capabilities in non-animal immunotoxicology and drug development\, with particular expertise in advanced biologics. \nRead more about Alcyomics
URL:https://senzagen.com/event/act2026/
LOCATION:San Antonio\, TX\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2026/09/ACT-am26-banner-event-page.png
END:VEVENT
END:VCALENDAR